JobCannon
Tutte le competenze

EMA Approval Process

⬢ LIVELLO 2Settori
Medio
Impatto sullo stipendio
6 mesi
Tempo di apprendimento
Difficile
Difficoltà
1
Carriere
In sintesi

The EMA (European Medicines Agency) oversees approval of drugs, vaccines, and medical devices in Europe. The approval process is highly regulated with multiple phases (pre-clinical, clinical trials, dossier submission, review). EMA approval is required to market pharmaceuticals across EU countries. Learning the process takes 4-6 months for someone with pharma background; mastery (running successful approvals) takes 2-3 years. Regulatory managers earn €70-120K because they prevent costly delays, each month of delay costs companies €5-15M in lost sales.

Cos'è EMA Approval Process

The EMA (European Medicines Agency) is the regulatory body responsible for approving human and veterinary medicines across European Union member states. The approval process requires pharmaceutical companies to submit comprehensive dossiers demonstrating safety, efficacy, and quality. These dossiers contain preclinical studies (lab and animal tests), clinical trial results (human testing), manufacturing information, and risk management plans. The EMA operates multiple review pathways. The centralized procedure is fastest: a single EMA committee reviews globally and issues one approval valid across all EU countries. Decentralized and mutual recognition procedures involve multiple national regulators and take longer. Once approved, companies must maintain compliance, report adverse events, and update safety data annually.

🔧 STRUMENTI ED ECOSISTEMA
eCTD (electronic Common Technical Document)EudraLex guidance documentsClinical trial management softwareRegulatory information managementQuality Overall Summary documents

💰 Stipendio per regione

RegioneLivello baseMidLivello esperto
USA$75k$120k$180k
UK£50k£80k£120k
EU€55k€90k€140k
CANADAC$80kC$130kC$190k

🎯 Carriere che usano EMA Approval Process

Regulatory Affairs Specialist

❓ Domande frequenti

What's the difference between centralized, decentralized, and mutual recognition procedures?
Centralized: Single EMA review, valid across all EU. Faster for most drugs (60 days assessment). Decentralized: One EU country leads, others follow. Mutual recognition: Parallel applications in multiple countries. Choose centralized for innovative drugs, decentralized for generic/routine.
How long does EMA approval actually take?
Standard review: 210 days (6-7 months). Accelerated review: 150 days if drug addresses unmet need. PRAC assessment (post-market safety): can add 30-90 days. Total from first submission to approval: typically 8-14 months including revisions.
What gets a company a PRAC review hold?
Safety signals in pre-clinical or Phase 2 data. Unexplained serious adverse events. Lack of genotoxicity data. Manufacturing issues. EMA sends Major Objections (MOs); company must respond with data/analysis. Average 2-3 rounds of MOs before approval.
Can I appeal an EMA rejection?
Yes, via appeal procedure. File formal appeal document + new data within 60 days. Takes 6-9 months. Success rate: ~20% (only if new evidence is compelling). Usually better to redesign the drug or run more trials.
What's a Risk Management Plan and when is it required?
RMP identifies safety risks and mitigation strategies. Required for all EMA submissions. Identifies known risks (from trials), unknown risks (will monitor post-market), and risk mitigation (restrictions, monitoring, education). Updated every 5 years.

Non sei sicuro che questa competenza faccia per te?

Fai il Career Match — ti suggeriremo i percorsi giusti.

Trova le competenze adatte a te →

Trova il tuo percorso di carriera ideale

Abbinamento basato sulle competenze per 2521 carriere. Gratis, ~3 minuti.

Fai il Career Match — gratis →